Top Markets
Coin of the day
Alpha Cognition Inc Alpha Cognition Inc

Alpha Cognition Inc

ACOG
Pozycja w akcjach #19830
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Cena akcji
$9.61
Kapitalizacja rynkowa
$149.33M
Zmiana (1 dzień)
-1.39%
Zmiana (1 rok)
24.38%
Kraj
US
Handel Alpha Cognition Inc (ACOG)

Kategoria

Historia ceny akcji dla Alpha Cognition Inc (ACOG)
Najwyższa cena zamknięcia: $9.07 dnia 2026-08-01

Najniższa cena zamknięcia: $6.45 dnia 2024-11-01
Historia cen akcji firmy Alpha Cognition Inc od 2024 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 13.45%
2025 7.90%
2024 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$122.47 -12.38%
AU
$772.27 7.33%
CH